HSF1 and cancer: Overall, the study highlights aptamers’ potential for precise inhibition of HSF1 in cancer while minimizing off-target effects, providing a novel strategy to suppress cancer cell growth and survival by blocking HSF1’s DNA-binding activity (Salamanca et al., 2014).